Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2017

View Archived Issues

Bayer and DKFZ disclose novel AhR antagonists for cancer

New rat model captures characteristics of AKT3 hemimegencephaly

Principia Biopharma begins clinical studies of PRN-1008 in ITP

Novel alphaVbeta3 antagonists show promise for osteoporosis

UMN Pharma returns influenza vaccine program rights to Protein Sciences

Allakos secures series B financing to advance its development programs

New formulation of Oncaspar approved in Europe

X-Chem enters research collaboration with Abilita Bio

reMYND and Novo Nordisk enter license agreement for ReS-39 in diabetes

FDA approves Pfizer's infliximab biosimilar Ixifi

Targeting potassium channel Kv7.2 may improve Dravet syndrome

Glenmark Pharmaceuticals' phase III study of Ryaltris meets primary endpoint

NIH grant supports IBBR's research into the TCR signaling mechanism

Positive first-in-human data for new complement C3 inhibitor AMY-10

Novel mutation in PIGQ gene tied to epileptic encephalopathy

Bristol-Myers Squibb and Ono Pharmaceutical sign license agreement for ONO-4578

JCR reports topline results from phase I/II study of JR-141 in Hunter's syndrome

Meiji and Kaketsuken to enter into memorandum of understanding regarding new company

Novel PD-1 signaling inhibitors presented by Institute of Materia Medica of Beijing

Institute of Materia Medica of Beijing divulges salinomycin oxime ether derivatives

SLC22A12 inhibitors described in Institute of Materia Medica of Beijing patent

Scancell and Cancer Research UK partner to progress SCIB-2 into phase I/II study

Idera Pharmaceuticals patents antisense oligonucleotides for cancer

Vertex enters development agreement with CRISPR Therapeutics for gene-editing treatment

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...